ACRS Stock Performance and Key Statistics

ACRS has a current P/E ratio of -5.81

The ACRS stock has a trailing twelve month price-to sales (P/S) ratio of 42.57 while its price-to-book (P/B) value is 3.66.

ACRS's price-to-free-cashflow (P/FCF) ratio is -7.07, an indicator that is currently being trending upward.

Based on ACRS's recent bid, its distance from 20 days simple moving average is -7.6%. It is -3.99% apart from 50 days simple moving average, and it is 39.79% apart from 200 days simple moving average.

The 52-week high for ACRS is $4.89 which is -35.99% away from the current price level whereas the distance of that from the 52-week low of $1.05 stands at 198.1%.

The performance of ACRS stock was not encouraging with most of its significant price indicators in green. Aclaris Therapeutics, Inc.(NASDAQ: ACRS) shares have moved upward +6.27% or $0.18 in the latest trading session and have gained 47.18% year-to-date (YTD). The stock has gained nearly 76.49% over the past year. After moving 133.16% over the trailing 3-month period, the stock is 170.12% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 66.54% a week and 46.2% a month.

The current 14-day RSI for ACRS stock is 43.46. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Aclaris Therapeutics, Inc. (ACRS) has a 14-day ATR of 0.28.

After closing at $2.87 with 108.35M of its shares outstanding, the current enterprise value of ACRS is roughly 43.53M.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is up 76.49% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 12.64%. ACRS stock price is also up 47.18% on its value in year-to-date trading.

The number outstanding shares of ACRS is 108.35M, and of these 85.19% shares are freely available for trading. On average, ACRS stock has traded 2.06M shares per day for the past 10 days. A total of 4.85M shares changed hands during the last trading session with the average session volume of 1.86M shares.